((自动化翻译由路透提供，请见免责声明 ))
10月7日 - ** 巧克力生产商好时 股价下跌 ~2%，报收于 188.17 美元
** 伯恩斯坦将该公司股票评级从 "跑赢大盘 "下调至 "跑输大盘"，并将目标价从 230 美元下调至 205 美元，原因是 GLP-1 的不利因素可能导致销量恢复低于预期，同时将汤料生产商金宝（Campbell）的评级上调至 "跑赢大盘"。
** 伯恩斯坦补充说，渠道调查显示，GLP-1 药物在复合药房领域的销售 "非常可观，而且还在增长"。
** 食品消费模式与 GLP-1 患者的饮食习惯一致，富含蛋白质的食品和饮料的消费模式是积极的，而甜味零食和快餐的消费模式是消极的
** 虽然我们无法断定目前美国 GLP-1 药物的复方制剂市场有多大，但有几个指标表明，该市场可能比我们之前想象的要大。
** 截至上次收盘，HSY 年累计上涨约 3
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.